Antibody responses to two-dose COVID-19 vaccination in people living with HIV

In a research study originally released as a preprint, and now published in npj vaccines, Drs. Zabrina Brumme and Mark Brockman, from the BC Centre for Excellence in HIV/AIDSĀ and Simon Fraser University, evaluated antibody responses to COVID-19 vaccines in people living with HIV who were receiving suppressive antiretroviral therapy.